Skip to main content
CNXC logo

CNXC · Concentrix Corp · Documents

Track CNXC — free
$30.46 +0.19 (+0.63%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.85B
Shares
61.11M
Volume · Nov 18 650.98K Avg daily vol (3M) 1.46M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $9.83B up 2.2% 10-K filed Jan 28, 2026 Quarterly report FY2026 Q3 Revenue $2.45B down 1.2% 10-Q filed Oct 7, 2026 Latest results Financial results 8-K filed Sep 29, 2026 Earnings call Q3 2026 earnings call Held Sep 29, 2026
2026
Nov 3
Current report 8-K
Chinnu Susan Varghese to succeed Andre Valentine as CFO

Concentrix Corporation announced that Chinnu Susan Varghese will succeed Andre Valentine as Chief Financial Officer effective December 1, 2026, joining November 9, 2026; Valentine is expected to remain through the second quarter of fiscal 2027 to provide transition support.

Director or officer change, or executive pay
3 source passages
On November 3, 2026, Concentrix Corporation (the “Company”) announced that Chinnu Susan Varghese will succeed Andre Valentine as the Company’s Chief Financial Officer, effective December 1, 2026. Mr. Valentine will continue to serve as Chief Financial Officer in the near term and is expected to remain with the Company through the second quarter of fiscal 2027 to provide transition support for Ms. Varghese. Ms. Varghese will join the Company on November 9, 2026 and assume the role of Chief Financial Officer on December 1, 2026. Open the document at this passage
Oct 7
Quarterly report 10-Q FY2026 Q3, ended Aug 31
Quarterly report for FY2026 Q3

Concentrix Corporation recorded a non-cash goodwill impairment charge of $1,050.0 million during the three and nine months ended August 31, 2026; nine-month revenue increased 2.0%, while three-month revenue decreased 1.2%.

Revenue $2.45B ▼ 1.2% Net loss $988.11M Diluted EPS -$16.24
Read from the MD&A section
Sep 29
Earnings call
Q3 2026 earnings call

Concentrix reported third quarter 2026 revenue of approximately $2.45 billion, non-GAAP operating income of $309 million and non-GAAP diluted EPS of $2.92 per share; fourth quarter revenue is expected at $2.41 to $2.46 billion.

Sep 29
Current report 8-K
Financial results

Concentrix reported third-quarter revenue of $2,453.7 million and non-GAAP diluted EPS of $2.92, despite a $1,050.0 million goodwill impairment. It increased its quarterly dividend to $0.37 per share and guided fiscal 2026 revenue to $9.827 billion to $9.877 billion.

Jul 2
Quarterly report 10-Q FY2026 Q2, ended May 31
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $2.46B ▲ 1.9% Net income $55.28M ▲ 31.3% Diluted EPS $0.86 ▲ 36.5%
Apr 3
Quarterly report 10-Q FY2026 Q1, ended Feb 28
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $2.5B ▲ 5.4% Net income $21.59M ▼ 69.3% Diluted EPS $0.33 ▼ 68.3%
Feb 13
Proxy statement DEF 14A Meeting Mar 25, 2026
Proxy statement AI summary on its way
Feb 13
Current report 8-K Events of Feb 12
Other events AI summary on its way
Jan 28
Annual report 10-K FY2025, ended Nov 30
Annual report for FY2025 AI summary on its way
Revenue $9.83B ▲ 2.2% Net loss $1.28B Diluted EPS -$20.36
2025
Oct 3
Quarterly report 10-Q FY2025 Q3, ended Aug 31
Quarterly report for FY2025 Q3
Revenue $2.48B ▲ 4.0% Net income $88.11M ▲ 429.8% Diluted EPS $1.34 ▲ 436.0%
Jul 3
Quarterly report 10-Q FY2025 Q2, ended May 31
Quarterly report for FY2025 Q2
Revenue $2.42B ▲ 1.5% Net income $42.09M ▼ 37.0% Diluted EPS $0.63 ▼ 35.7%
Apr 4
Quarterly report 10-Q FY2025 Q1, ended Feb 28
Quarterly report for FY2025 Q1
Revenue $2.37B ▼ 1.3% Net income $70.26M ▲ 34.8% Diluted EPS $1.04 ▲ 36.8%
Jan 28
Annual report 10-K FY2024, ended Nov 30
Annual report for FY2024
Revenue $9.62B ▲ 35.2% Net income $251.22M ▼ 20.0% Diluted EPS $3.71 ▼ 34.9%
2024
Oct 4
Quarterly report 10-Q FY2024 Q3, ended Aug 31
Quarterly report for FY2024 Q3
Revenue $2.39B ▲ 46.2% Net income $16.63M ▼ 78.6% Diluted EPS $0.25 ▼ 83.2%
Showing 1–50 of 165 documents
Key facts CIK 1803599 CUSIP 20602D101 13F (30d) 283 filings 259 filers Visit website Investor relations